Nobel Prize in Chemistry 2026: Shankar Balasubramanian and David Klenerman (University of Cambridge) for the development of next-generation DNA sequencing (announcement October 7, 2026)
Pending
✦ AI-generated prediction
Published on 1. October 2026
·
Predicted for 7. October 2026
·
Based on: Speculative
The Royal Swedish Academy of Sciences announces the Nobel Prize in Chemistry on October 7. Shankar Balasubramanian and David Klenerman (both University of Cambridge) are the main favorites on small, illiquid prediction markets (Kalshi, Polymarket) for their invention of Sequencing by Synthesis (SBS), the foundation of modern NGS platforms — above all Illumina — which has revolutionized personalized medicine, oncology, and infectious disease epidemiology. Other strongly backed candidates: Pieter Cullis (UBC) for lipid nanoparticle technology (mRNA vaccines) and the skeletal editing trio Sarpong/Levin/Miranda. Kalshi: Balasubramanian/Klenerman as frontrunners without published exact odds; market positioning per Chemistry World and The Scientist implies approximately 20–28% for this duo. Nobel committees historically act surprisingly; probability set at 25%.
Data basis for this prediction
- Kalshi Nobel Chemistry 2026 (kxnobelchem-26): Balasubramanian & Klenerman als Marktfavoriten (Stand 01.10.2026)
- Chemistry World/The Scientist: 'Nobel Prize Chemistry 2026 Predictions' — NGS-Forscher unter Top-3-Picks, Oktober 2026
- ACS Webinar 2026: 'Who Will Win the #ChemNobel?' — Balasubramanian/Klenerman am häufigsten genannt
- RicherNews, Oktober 2026: '2026 Nobel Prize: The Betting Market's Shortlist' — DNA-Sequenzierung im Fokus
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
💻 Technology
✦ AI
Ethereum trades at $2,680 on Oct 1, 2026 (CoinGecko). The $3,500 threshold is 30.6% above current price — achievable within 6 months but ambitious. Forecaster consensus for October 2026 alone: DailyForex $2,600–$3,100; CoinDCX $2,950; Changelly $3,045–$3,070 (minimum target). The $3,500 level thus represents a natural projection of October momentum into Q1 2027. Bullish drivers: ETH staking yields remain attractive; Layer-2 adoption (Base, Arbitrum, Optimism) accelerates network utilization; historical BTC halving cycle patterns favor altcoin rallies from Q4 2026. Headwinds: US SEC regulatory action, macro-driven risk aversion, or decoupling from BTC. No direct Polymarket market found for this horizon; 30% probability conservatively derived from forecaster spread and ETH volatility profile.
💻 Technology
✦ AI
TSMC posted a record August 2026 revenue of NT$514.806 billion (+53.3% YoY, +10.1% MoM). Cumulative Jan–Aug 2026 revenues: NT$3,386.87 billion (+39.3% YoY). Seasonal tailwinds from the Apple iPhone high season in September and sustained Nvidia/AMD orders support a similarly strong September figure. Estimated Sep-2025 base of NT$325–335 billion implies a +53% YoY September 2026 figure of ~NT$498–513 billion, making the NT$500 billion threshold approximately the median of that range. Headlines indicate another strong September ('can't keep up with demand'). No Polymarket price found for this specific threshold.
💻 Technology
✦ AI
ASML (NASDAQ/Euronext: ASML) guided Q3 2026 net sales to €11.0–12.0 billion at 55–57% gross margin. In Q2 2026 the company posted €9.3 billion net sales, beating guidance ('Q2 2026 beats guidance as AI demand lifts outlook'). Full-year 2026 guidance was raised to €43–45 billion net sales. Exceeding the guidance midpoint of €11.5 billion requires +23.7% sequential growth from Q2 — consistent with ASML's typical H2 seasonal strength driven by EUV system deliveries. Given the Q2 guidance beat and raised full-year outlook, a midpoint beat is plausible at ~62%. No specific Polymarket price found.